Singapore markets closed

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
165.30-1.84 (-1.10%)
At close: 04:00PM EDT
165.47 +0.17 (+0.10%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close167.14
Open167.54
Bid165.15 x 1000
Ask165.50 x 900
Day's range165.15 - 167.94
52-week range155.72 - 186.69
Volume14,591,114
Avg. volume6,842,159
Market cap434.603B
Beta (5Y monthly)0.59
PE ratio (TTM)24.06
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield4.52 (2.70%)
Ex-dividend date22 Aug 2022
1y target estN/A
  • Business Wire

    Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

    NEW BRUNSWICK, N.J., August 09, 2022--Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14th, at the Sheraton New York Hotel in New York. Joaquin Duato, Chief Executive Officer, and Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m. (Eastern Time).

  • Business Wire

    Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson

    NEW BRUNSWICK, N.J., August 08, 2022--Johnson & Johnson (NYSE: JNJ) ("the Company") announced today that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice President, Pharmaceuticals, R&D, and pursue other opportunities outside of the Company. William Hait, M.D., Ph.D., will serve as interim head of the Pharmaceutical R&D organization until new leadership is identified.

  • Business Wire

    Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference

    NEW BRUNSWICK, N.J., August 02, 2022--Johnson & Johnson (NYSE: JNJ) will participate in the 2022 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Wednesday, September 7th. Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).